pipette
ESEspañol

Cholinergic modulation engages a CHRM1-IL-17 neuroimmune axis to promote diabetic wound repair

Z. Li, G. Theocharidis, S. Lee, N. Kalavros, S. U. Nagalakshmi, M. Contreras, E.-A. Valsami, H. Nam, M. Guan, G. Chu, I. Mezghani, E. Wang, B. J. Sumpio, J. Hou, M. Gennari-Felipe, J. Gilman, N. Lafuente-Gomez, L. Maeso Aragon, N. Dimitrakakis, A. Arruda de Amaral, S. Wang, I. S. Vlachos, D. J. Mooney, A. Veves

PreprintReal-world use

In the authors' words

Chronic non-healing wounds are a major complication of diabetes, where persistent inflammation fails to transition into effective tissue repair (1-3). Here we identify cholinergic modulation as a mechanism that promotes productive inflammation and diabetic wound healing. Using a healing-associated fibroblast signature derived from single-cell profiling of human diabetic foot ulcers (3), we identified the acetylcholinesterase (AChE) inhibitor metrifonate as a candidate inducer of reparative wound programs. Topical delivery accelerated healing in diabetic mice and increased acetylcholine availability within the wound. Complementary receptor pharmacology identified muscarinic acetylcholine receptor 1 (CHRM1) as the principal receptor mediating the reparative response. Transcriptomic and cellular analyses revealed early induction of IL-17-associated inflammatory programs and enrichment of CHRM1NK1.1 innate lymphocytes. Depletion of NK1.1 cells or neutralization of IL-17A abolished the pro-healing effect, whereas spatial transcriptomics revealed treatment-associated organization of NK cells within vascular niches. Localized treatment further promoted repair in diabetic porcine wounds and human skin models. Together, these findings identify a CHRM1-IL-17 neuroimmune axis linking cholinergic modulation to diabetic wound repair and establish local AChE inhibition as a potential therapeutic strategy for chronic wounds.

Main resultThe abstract does not state a limitation.

Appeared: Tuesday, November 10. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.06.764960